Endothelial Cell News 4.30 September 9, 2019 | |
| |
TOP STORYEndothelial CDS2 Deficiency Causes VEGFA-Mediated Vascular Regression and Tumor Inhibition In tumor models, CDP-diacylglycerol synthetase-2 (CDS2) deficiency enhanced the level of tumor-secreted vascular endothelial growth factor-a (VEGFA), which in-turn trapped tumors into a VEGFA-induced vessel regression situation, leading to suppression of tumor growth. [Cell Res] Full Article | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)A Biomimetic Pancreatic Cancer on-Chip Reveals Endothelial Ablation via ALK7 Signaling Pancreatic ductal adenocarcinoma (PDAC) cells invaded through intervening matrix, into vessel lumen, and ablated the endothelial cells, leaving behind tumor-filled luminal structures. Endothelial ablation was also observed in in vivo PDAC models. [Sci Adv] Full Article | Press Release VE-Cadherin Is Required for Lymphatic Valve Formation and Maintenance Investigators showed that the adherens junction protein VE-cadherin was required for the upregulation of valve-specific transcription factors. Conditional deletion of VE-cadherin in vivo prevented valve formation in the embryo and caused postnatal regression of nearly all lymphatic valves in multiple tissues. [Cell Rep] Full Article | Graphical Abstract The authors describe a two-step differentiation protocol to derive brain capillary-like endothelial cells from human pluripotent stem cells. [Stem Cell Reports] Full Article Researchers investigated the contribution of mitochondrial dysfunction to the senescence of human endothelial progenitor cells expanded in vitro and the underlying molecular mechanism. [Angiogenesis] Abstract Inducing mitochondrial ROS production in microvascular endothelial cells (MVECs) from normoxic rats increased fragmentation. Calcium entry induced by treatment with the TRPV4 agonist, GSK1017920A, was significantly increased in sugen/hypoxia-MVECs and was attenuated with MitoQ treatment. [Am J Physiol Lung Cell Mol Physiol] Abstract Scientists showed that glycolysis was essential for tip cell differentiation, whereas both glycolysis and mitochondrial respiration occurred during proliferation of non-tip cells and in sprouting angiogenesis in vitro and in vivo. [Sci Rep] Full Article Researchers identified the role of exosomes from ADSCs overexpressing miR-21 in regulating/promoting vascularization of endothelial cells. In vitro matrigel angiogenesis assay showed that exosomes secreted by ADSCs overexpressing miR-21 significantly promoted the vascularization of HUVECs. [Sci Rep] Full Article Investigators demonstrated that aged endothelial cells (ECs) were larger than young ECs and that age-dependent increases in EC size controlled EC proliferation and senescence through CDC42-yes-associated protein (YAP1) signaling. [Aging (Albany NY)] Full Article Scientists demonstrated that magnesium sulfate was efficacious in blocking IL-1β-mediated-inflammation in HUVECs, at both the initiation and propagation phases of inflammation. [Pediatr Res] Abstract Secretion of angiogenic factors by cultured cells provided evidence for a potential mechanism underlying endogenous endothelial cell repair in amyotrophic lateral sclerosis (ALS) through human bone marrow endothelial progenitor cell transplantation, leading to restored barrier integrity. [Brain Res] Abstract Subscribe to one of our other 19 science newsletters such as Extracellular Matrix News & Cell Therapy News. | |
| |
REVIEWSHallmarks of Endothelial Cell Metabolism in Health and Disease Endothelial cells (ECs), often differently from other cell types, rely on distinct metabolic pathways to survive and form new blood vessels; manipulation of EC metabolic pathways alone suffices to alter vessel sprouting; and perturbations of these metabolic pathways can underlie excess formation of new blood vessels in cancer and ocular diseases. [Cell Metab] Abstract Visit our reviews page to see a complete list of reviews in the endothelial cell research field. | |
| |
INDUSTRY NEWSREGENXBIO Inc. and Clearside Biomedical, Inc. announced an option and license agreement for exclusive worldwide rights to Clearside’s proprietary, in-office SCS Microinjector™ for the delivery of RGX-314 to the suprachoroidal space to treat wet age-related macular degeneration, diabetic retinopathy and other conditions for which anti-VEGF treatment is currently the standard of care. [REGENXBIO Inc.] Press Release Kowa Company Ltd. submitted an Investigational New Drug (IND) application to the FDA in order to commence a Phase II clinical study. [Kowa Company Ltd. (PR Newswire Association, LLC.)] Press Release | |
| |
POLICY NEWSUS Funding Scramble Leaves Science Agencies in Limbo The US Congress has a busy few weeks in store. When lawmakers return from their summer break on 9 September, they’ll have just three weeks to hammer out a 2020 spending deal – and funding for the National Institutes of Health, National Science Foundation and other key science agencies is on the line. [Nature News] Editorial Animal Registries Aim to Reduce Bias Registries ask researchers to detail their hypotheses, experimental strategy and analytical plans before studies begin. The intention is to prevent teams from simply cherry-picking significant or desirable findings and to supply the scientific community with a way of learning about experiments that would otherwise go unpublished. [Nature News] Editorial
| |
EVENTSNEW Stromal Cells in Immunity and Disease Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Science Manager – Vascular Biology (Max Delbrück Center for Molecular Medicine) NEW PhD and Postdoctoral Positions – Neurovascular Biology (Université Libre de Bruxelles) Research Fellow – Vascular Stem Cell Biology (Queen’s University Belfast) Scientific Communications Coordinator (STEMCELL Technologies Inc.) Senior Laboratory Research Scientist – Endothelial Cell Research (The Francis Crick Institute) Faculty Positions – Basic and Translational Cardiovascular Sciences (New York University) Postdoctoral Fellow – Cardiovascular Physiology (University of California, San Diego) Postdoctoral Fellowship – Cancer Therapeutics & Angiogenesis (Boston Children’s Hospital) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Endothelial Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|